Effects of Probiotics in Preterm Infants: A Network Meta-analysis

Pediatrics
Q1
Dec 2020
Citations:77
Influential Citations:1
Systematic Reviews / Meta-Analyses
84
S2 IconPDF Icon

Enhanced Details

Methods
Design: Bayesian network meta-analysis of randomized controlled trials evaluating probiotic supplementation in preterm infants. Population: premature infants (<37 weeks gestation or birth weight <2500 g).
Results
Synbiotic regimens outperform single-strain probiotics for key outcomes in preterm infants. Bifidobacterium + Lactobacillus vs placebo: mortality RR 0.56 (95% credible interval 0.34-0.84); NEC RR 0.47 (0.27-0.79). Lactobacillus + Prebiotic vs placebo: NEC morbidity RR 0.06 (0.01-0.41); sepsis morbidity RR 0.18 (0.07-0.53). Bifidobacterium + Prebiotic had highest probability of lowest mortality (SUCRA 83.94%); Lactobacillus + Prebiotic had highest probability of the lowest NEC (SUCRA 95.62%). For secondary outcomes, Lactobacillus + Prebiotic ranked highest for time to full enteral feeding (SUCRA 89.41%) and length of hospital stay (SUCRA 82.13%). Overall, combining prebiotic with probiotic (synbiotic), especially Lactobacillus or Bifidobacterium, is recommended to optimize health outcomes in preterm infants.
Limitations
Data for extremely low birth weight or gestational age were underreported in some trials.

Abstract

Probiotics have proven to be effective in promoting premature infants’ health, but the optimal usage is unknown. CONTEXT: Probiotics have proven to be effective in promoting premature infants’ health, but the optimal usage is unknown. OBJECTIVE: To c...